Understanding Traction Studies: Read Evidence | SizeGenetics

Episode SummaryThis episode is a practical guide to understanding penile traction therapy studies — how to evaluate evidence, spot bias, and decide what research actually applies to you. We walk through key meta-analyses, randomized trials, and prospective studies that form the clinical foundation of traction therapy.Key Findings2023 Almsaoud Meta-Analysis: 12 studies, 1,000+ patients — 1.9 cm mean length gain, 27% curvature reduction, 82% adherence, 80% satisfactionToussi 2021 RCT: 82 post-prostatectomy men — 1.6 cm gain vs 0.3 cm control (p value of 0.01)Gontero 2009: 15 men over 6 months — 1.3 cm mean gain, no significant adverse eventsNikoobakht 2011: 1.7 cm gain in flaccid and stretched length with dose-response patternEvaluation Framework: Check patient population, funding source, study design, and verify on PubMedThe SciencePenile traction therapy applies calibrated mechanical tension that activates mechanotransduction — the cellular response to sustained force — leading to measurable tissue remodeling in the tunica albuginea when protocols are followed consistently.About SizeGeneticsFDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.ResourcesFull Guide: Understanding Penile Traction StudiesClinical Studies OverviewPenile Traction Therapy ResultsStudies DatabaseDoes Traction Therapy Work?Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.